The Oncology Drug Discovery Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Oncology Drug Discovery Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Oncology Drug Discovery Services market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oncology Drug Discovery Services market has been segmented into:
Identification Service
Authentication Service
Hit-to-lead and Lead Optimization Services
Others
By Application, Oncology Drug Discovery Services has been segmented into:
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncology Drug Discovery Services market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncology Drug Discovery Services markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncology Drug Discovery Services market.
The report offers in-depth assessment of the growth and other aspects of the Oncology Drug Discovery Services market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Oncology Drug Discovery Services Market Share Analysis
Oncology Drug Discovery Services competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncology Drug Discovery Services sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncology Drug Discovery Services sales, revenue and market share for each player covered in this report.
The major players covered in Oncology Drug Discovery Services are:
Charles River
ChemPartner
GenScript
Evotec
Zumutor
GE Healthcare Life Sciences
Onconova
TCG Lifesciences
Horizon Discovery
Aquila BioMedical
Envigo
HD Biosciences
Vichem Chemie
DiverChim
Syncom
GVK Biosciences
WuXi AppTec
Aurora
NuChem Therapeutics
Among other players domestic and global, Oncology Drug Discovery Services market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Oncology Drug Discovery Services Market Overview
1.1 Product Overview and Scope of Oncology Drug Discovery Services
1.2 Classification of Oncology Drug Discovery Services by Type
1.2.1 Global Oncology Drug Discovery Services Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Oncology Drug Discovery Services Revenue Market Share by Type in 2019
1.2.3 Identification Service
1.2.4 Authentication Service
1.2.5 Hit-to-lead and Lead Optimization Services
1.2.6 Others
1.3 Global Oncology Drug Discovery Services Market by Application
1.3.1 Overview: Global Oncology Drug Discovery Services Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Others
1.4 Global Oncology Drug Discovery Services Market by Regions
1.4.1 Global Oncology Drug Discovery Services Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Oncology Drug Discovery Services (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oncology Drug Discovery Services Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncology Drug Discovery Services Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Drug Discovery Services Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oncology Drug Discovery Services Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Drug Discovery Services Status and Prospect (2015-2025)
2 Company Profiles
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River SWOT Analysis
2.1.4 Charles River Product and Services
2.1.5 Charles River Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.2 ChemPartner
2.2.1 ChemPartner Details
2.2.2 ChemPartner Major Business
2.2.3 ChemPartner SWOT Analysis
2.2.4 ChemPartner Product and Services
2.2.5 ChemPartner Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.3 GenScript
2.3.1 GenScript Details
2.3.2 GenScript Major Business
2.3.3 GenScript SWOT Analysis
2.3.4 GenScript Product and Services
2.3.5 GenScript Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.4 Evotec
2.4.1 Evotec Details
2.4.2 Evotec Major Business
2.4.3 Evotec SWOT Analysis
2.4.4 Evotec Product and Services
2.4.5 Evotec Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.5 Zumutor
2.5.1 Zumutor Details
2.5.2 Zumutor Major Business
2.5.3 Zumutor SWOT Analysis
2.5.4 Zumutor Product and Services
2.5.5 Zumutor Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.6 GE Healthcare Life Sciences
2.6.1 GE Healthcare Life Sciences Details
2.6.2 GE Healthcare Life Sciences Major Business
2.6.3 GE Healthcare Life Sciences Product and Services
2.6.4 GE Healthcare Life Sciences Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.7 Onconova
2.7.1 Onconova Details
2.7.2 Onconova Major Business
2.7.3 Onconova Product and Services
2.7.4 Onconova Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.8 TCG Lifesciences
2.8.1 TCG Lifesciences Details
2.8.2 TCG Lifesciences Major Business
2.8.3 TCG Lifesciences Product and Services
2.8.4 TCG Lifesciences Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.9 Horizon Discovery
2.9.1 Horizon Discovery Details
2.9.2 Horizon Discovery Major Business
2.9.3 Horizon Discovery Product and Services
2.9.4 Horizon Discovery Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aquila BioMedical
2.10.1 Aquila BioMedical Details
2.10.2 Aquila BioMedical Major Business
2.10.3 Aquila BioMedical Product and Services
2.10.4 Aquila BioMedical Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.11 Envigo
2.11.1 Envigo Details
2.11.2 Envigo Major Business
2.11.3 Envigo Product and Services
2.11.4 Envigo Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.12 HD Biosciences
2.12.1 HD Biosciences Details
2.12.2 HD Biosciences Major Business
2.12.3 HD Biosciences Product and Services
2.12.4 HD Biosciences Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.13 Vichem Chemie
2.13.1 Vichem Chemie Details
2.13.2 Vichem Chemie Major Business
2.13.3 Vichem Chemie Product and Services
2.13.4 Vichem Chemie Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.14 DiverChim
2.14.1 DiverChim Details
2.14.2 DiverChim Major Business
2.14.3 DiverChim Product and Services
2.14.4 DiverChim Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.15 Syncom
2.15.1 Syncom Details
2.15.2 Syncom Major Business
2.15.3 Syncom Product and Services
2.15.4 Syncom Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.16 GVK Biosciences
2.16.1 GVK Biosciences Details
2.16.2 GVK Biosciences Major Business
2.16.3 GVK Biosciences Product and Services
2.16.4 GVK Biosciences Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.17 WuXi AppTec
2.17.1 WuXi AppTec Details
2.17.2 WuXi AppTec Major Business
2.17.3 WuXi AppTec Product and Services
2.17.4 WuXi AppTec Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.18 Aurora
2.18.1 Aurora Details
2.18.2 Aurora Major Business
2.18.3 Aurora Product and Services
2.18.3 Aurora Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
2.19 NuChem Therapeutics
2.19.1 NuChem Therapeutics Details
2.19.2 NuChem Therapeutics Major Business
2.19.3 NuChem Therapeutics Product and Services
2.19.4 NuChem Therapeutics Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Oncology Drug Discovery Services Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncology Drug Discovery Services Players Market Share
3.2.2 Top 10 Oncology Drug Discovery Services Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Oncology Drug Discovery Services Revenue and Market Share by Regions
4.2 North America Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
4.3 Europe Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
4.5 South America Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
5 North America Oncology Drug Discovery Services Revenue by Countries
5.1 North America Oncology Drug Discovery Services Revenue by Countries (2015-2020)
5.2 USA Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
5.3 Canada Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
5.4 Mexico Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
6 Europe Oncology Drug Discovery Services Revenue by Countries
6.1 Europe Oncology Drug Discovery Services Revenue by Countries (2015-2020)
6.2 Germany Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
6.3 UK Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
6.4 France Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
6.5 Russia Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
6.6 Italy Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Oncology Drug Discovery Services Revenue by Regions
7.1 Asia-Pacific Oncology Drug Discovery Services Revenue by Regions (2015-2020)
7.2 China Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
7.3 Japan Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
7.4 Korea Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
7.5 India Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
8 South America Oncology Drug Discovery Services Revenue by Countries
8.1 South America Oncology Drug Discovery Services Revenue by Countries (2015-2020)
8.2 Brazil Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
8.3 Argentina Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Oncology Drug Discovery Services by Countries
9.1 Middle East & Africa Oncology Drug Discovery Services Revenue by Countries (2015-2020)
9.2 Saudi Arabia Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
9.3 UAE Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
9.4 Egypt Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
9.5 South Africa Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Oncology Drug Discovery Services Revenue and Market Share by Type (2015-2020)
10.2 Global Oncology Drug Discovery Services Market Forecast by Type (2019-2024)
10.3 Identification Service Revenue Growth Rate (2015-2025)
10.4 Authentication Service Revenue Growth Rate (2015-2025)
10.5 Hit-to-lead and Lead Optimization Services Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Oncology Drug Discovery Services Market Segment by Application
11.1 Global Oncology Drug Discovery Services Revenue Market Share by Application (2015-2020)
11.2 Oncology Drug Discovery Services Market Forecast by Application (2019-2024)
11.3 Research Institutes Revenue Growth (2015-2020)
11.4 Pharmaceutical Companies Revenue Growth (2015-2020)
11.5 Biotechnology Companies Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Oncology Drug Discovery Services Market Size Forecast (2021-2025)
12.1 Global Oncology Drug Discovery Services Market Size Forecast (2021-2025)
12.2 Global Oncology Drug Discovery Services Market Forecast by Regions (2021-2025)
12.3 North America Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
12.4 Europe Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
12.6 South America Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Oncology Drug Discovery Services Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncology Drug Discovery Services by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncology Drug Discovery Services Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Oncology Drug Discovery Services Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Oncology Drug Discovery Services Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Charles River Corporate Information, Location and Competitors
Table 7. Charles River Oncology Drug Discovery Services Major Business
Table 8. Charles River Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 9. Charles River SWOT Analysis
Table 10. Charles River Oncology Drug Discovery Services Product and Solutions
Table 11. Charles River Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. ChemPartner Corporate Information, Location and Competitors
Table 13. ChemPartner Oncology Drug Discovery Services Major Business
Table 14. ChemPartner Oncology Drug Discovery Services Total Revenue (USD Million) (2018-2019)
Table 15. ChemPartner SWOT Analysis
Table 16. ChemPartner Oncology Drug Discovery Services Product and Solutions
Table 17. ChemPartner Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. GenScript Corporate Information, Location and Competitors
Table 19. GenScript Oncology Drug Discovery Services Major Business
Table 20. GenScript Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 21. GenScript SWOT Analysis
Table 22. GenScript Oncology Drug Discovery Services Product and Solutions
Table 23. GenScript Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Evotec Corporate Information, Location and Competitors
Table 25. Evotec Oncology Drug Discovery Services Major Business
Table 26. Evotec Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 27. Evotec SWOT Analysis
Table 28. Evotec Oncology Drug Discovery Services Product and Solutions
Table 29. Evotec Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Zumutor Corporate Information, Location and Competitors
Table 31. Zumutor Oncology Drug Discovery Services Major Business
Table 32. Zumutor Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 33. Zumutor SWOT Analysis
Table 34. Zumutor Oncology Drug Discovery Services Product and Solutions
Table 35. Zumutor Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. GE Healthcare Life Sciences Corporate Information, Location and Competitors
Table 37. GE Healthcare Life Sciences Oncology Drug Discovery Services Major Business
Table 38. GE Healthcare Life Sciences Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 39. GE Healthcare Life Sciences SWOT Analysis
Table 40. GE Healthcare Life Sciences Oncology Drug Discovery Services Product and Solutions
Table 41. GE Healthcare Life Sciences Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Onconova Corporate Information, Location and Competitors
Table 43. Onconova Oncology Drug Discovery Services Major Business
Table 44. Onconova Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 45. Onconova SWOT Analysis
Table 46. Onconova Oncology Drug Discovery Services Product and Solutions
Table 47. Onconova Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. TCG Lifesciences Corporate Information, Location and Competitors
Table 49. TCG Lifesciences Oncology Drug Discovery Services Major Business
Table 50. TCG Lifesciences Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 51. TCG Lifesciences SWOT Analysis
Table 52. TCG Lifesciences Oncology Drug Discovery Services Product and Solutions
Table 53. TCG Lifesciences Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Horizon Discovery Corporate Information, Location and Competitors
Table 55. Horizon Discovery Oncology Drug Discovery Services Major Business
Table 56. Horizon Discovery Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 57. Horizon Discovery SWOT Analysis
Table 58. Horizon Discovery Oncology Drug Discovery Services Product and Solutions
Table 59. Horizon Discovery Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Aquila BioMedical Corporate Information, Location and Competitors
Table 61. Aquila BioMedical Oncology Drug Discovery Services Major Business
Table 62. Aquila BioMedical Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 63. Aquila BioMedical SWOT Analysis
Table 64. Aquila BioMedical Oncology Drug Discovery Services Product and Solutions
Table 65. Aquila BioMedical Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Envigo Corporate Information, Location and Competitors
Table 67. Envigo Oncology Drug Discovery Services Major Business
Table 68. Envigo Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 69. Envigo SWOT Analysis
Table 70. Envigo Oncology Drug Discovery Services Product and Solutions
Table 71. Envigo Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. HD Biosciences Corporate Information, Location and Competitors
Table 73. HD Biosciences Oncology Drug Discovery Services Major Business
Table 74. HD Biosciences Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 75. HD Biosciences SWOT Analysis
Table 76. HD Biosciences Oncology Drug Discovery Services Product and Solutions
Table 77. HD Biosciences Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Vichem Chemie Corporate Information, Location and Competitors
Table 79. Vichem Chemie Oncology Drug Discovery Services Major Business
Table 80. Vichem Chemie Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 81. Vichem Chemie SWOT Analysis
Table 82. Vichem Chemie Oncology Drug Discovery Services Product and Solutions
Table 83. Vichem Chemie Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. DiverChim Corporate Information, Location and Competitors
Table 85. DiverChim Oncology Drug Discovery Services Major Business
Table 86. DiverChim Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 87. DiverChim SWOT Analysis
Table 88. DiverChim Oncology Drug Discovery Services Product and Solutions
Table 89. DiverChim Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Syncom Corporate Information, Location and Competitors
Table 91. Syncom Oncology Drug Discovery Services Major Business
Table 92. Syncom Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 93. Syncom SWOT Analysis
Table 94. Syncom Oncology Drug Discovery Services Product and Solutions
Table 95. Syncom Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. GVK Biosciences Corporate Information, Location and Competitors
Table 97. GVK Biosciences Oncology Drug Discovery Services Major Business
Table 98. GVK Biosciences Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 99. GVK Biosciences SWOT Analysis
Table 100. GVK Biosciences Oncology Drug Discovery Services Product and Solutions
Table 101. GVK Biosciences Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. WuXi AppTec Corporate Information, Location and Competitors
Table 103. WuXi AppTec Oncology Drug Discovery Services Major Business
Table 104. WuXi AppTec Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 105. WuXi AppTec SWOT Analysis
Table 106. WuXi AppTec Oncology Drug Discovery Services Product and Solutions
Table 107. WuXi AppTec Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Aurora Oncology Drug Discovery Services Type and Application
Table 109. Aurora Oncology Drug Discovery Services Major Business
Table 110. Aurora Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 111. Aurora SWOT Analysis
Table 112. Aurora Oncology Drug Discovery Services Product and Solutions
Table 113. Aurora Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. NuChem Therapeutics Corporate Information, Location and Competitors
Table 115. NuChem Therapeutics Oncology Drug Discovery Services Major Business
Table 116. NuChem Therapeutics Oncology Drug Discovery Services Total Revenue (USD Million) (2017-2018)
Table 117. NuChem Therapeutics SWOT Analysis
Table 118. NuChem Therapeutics Oncology Drug Discovery Services Product and Solutions
Table 119. NuChem Therapeutics Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Global Oncology Drug Discovery Services Revenue (Million USD) by Players (2015-2020)
Table 121. Global Oncology Drug Discovery Services Revenue Share by Players (2015-2020)
Table 122. Global Oncology Drug Discovery Services Revenue (Million USD) by Regions (2015-2020)
Table 123. Global Oncology Drug Discovery Services Revenue Market Share by Regions (2015-2020)
Table 124. North America Oncology Drug Discovery Services Revenue by Countries (2015-2020)
Table 125. North America Oncology Drug Discovery Services Revenue Market Share by Countries (2015-2020)
Table 126. Europe Oncology Drug Discovery Services Revenue (Million USD) by Countries (2015-2020)
Table 127. Asia-Pacific Oncology Drug Discovery Services Revenue (Million USD) by Regions (2015-2020)
Table 128. South America Oncology Drug Discovery Services Revenue by Countries (2015-2020)
Table 129. South America Oncology Drug Discovery Services Revenue Market Share by Countries (2015-2020)
Table 130. Middle East and Africa Oncology Drug Discovery Services Revenue (Million USD) by Countries (2015-2020)
Table 131. Middle East and Africa Oncology Drug Discovery Services Revenue Market Share by Countries (2015-2020)
Table 132. Global Oncology Drug Discovery Services Revenue (Million USD) by Type (2015-2020)
Table 133. Global Oncology Drug Discovery Services Revenue Share by Type (2015-2020)
Table 134. Global Oncology Drug Discovery Services Revenue Forecast by Type (2021-2025)
Table 135. Global Oncology Drug Discovery Services Revenue by Application (2015-2020)
Table 136. Global Oncology Drug Discovery Services Revenue Share by Application (2015-2020)
Table 137. Global Oncology Drug Discovery Services Revenue Forecast by Application (2021-2025)
Table 138. Global Oncology Drug Discovery Services Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Oncology Drug Discovery Services Picture
Figure 2. Global Oncology Drug Discovery Services Revenue Market Share by Type in 2019
Figure 3. Identification Service Picture
Figure 4. Authentication Service Picture
Figure 5. Hit-to-lead and Lead Optimization Services Picture
Figure 6. Others Picture
Figure 7. Oncology Drug Discovery Services Revenue Market Share by Application in 2019
Figure 8. Research Institutes Picture
Figure 9. Pharmaceutical Companies Picture
Figure 10. Biotechnology Companies Picture
Figure 11. Others Picture
Figure 12. Global Oncology Drug Discovery Services Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Oncology Drug Discovery Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Oncology Drug Discovery Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Oncology Drug Discovery Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Oncology Drug Discovery Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Oncology Drug Discovery Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Oncology Drug Discovery Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Oncology Drug Discovery Services Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Oncology Drug Discovery Services Revenue Market Share in 2019
Figure 21. Global Top 10 Players Oncology Drug Discovery Services Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Oncology Drug Discovery Services Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Oncology Drug Discovery Services Revenue Market Share by Regions (2015-2020)
Figure 25. Global Oncology Drug Discovery Services Revenue Market Share by Regions in 2018
Figure 26. North America Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 27. Europe Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 29. South America Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 31. North America Oncology Drug Discovery Services Revenue Market Share by Countries (2015-2020)
Figure 32. North America Oncology Drug Discovery Services Revenue Market Share by Countries in 2019
Figure 33. USA Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 34. Canada Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 36. Europe Oncology Drug Discovery Services Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Oncology Drug Discovery Services Revenue Market Share by Countries in 2019
Figure 38. Germany Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 39. UK Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 40. France Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 41. Russia Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 42. Italy Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Oncology Drug Discovery Services Revenue Market Share by Regions (2015-2020)
Figure 44. Asia-Pacific Oncology Drug Discovery Services Revenue Market Share by Regions in 2019
Figure 45. China Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 46. Japan Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 47. Korea Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 48. India Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 50. South America Oncology Drug Discovery Services Revenue Market Share by Countries (2015-2020)
Figure 51. South America Oncology Drug Discovery Services Revenue Market Share by Countries in 2019
Figure 52. Brazil Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Oncology Drug Discovery Services Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Oncology Drug Discovery Services Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 57. UAE Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Oncology Drug Discovery Services Revenue and Growth Rate (2015-2020)
Figure 60. Global Oncology Drug Discovery Services Revenue Share by Type (2015-2020)
Figure 61. Global Oncology Drug Discovery Services Revenue Share by Type in 2019
Figure 62. Global Oncology Drug Discovery Services Market Share Forecast by Type (2021-2025)
Figure 63. Global Identification Service Revenue Growth Rate (2015-2020)
Figure 64. Global Authentication Service Revenue Growth Rate (2015-2020)
Figure 65. Global Hit-to-lead and Lead Optimization Services Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Oncology Drug Discovery Services Revenue Share by Application (2015-2020)
Figure 68. Global Oncology Drug Discovery Services Revenue Share by Application in 2019
Figure 69. Global Oncology Drug Discovery Services Market Share Forecast by Application (2021-2025)
Figure 70. Global Research Institutes Revenue Growth Rate (2015-2020)
Figure 71. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 72. Global Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Oncology Drug Discovery Services Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Oncology Drug Discovery Services Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Oncology Drug Discovery Services Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
Figure 78. Europe Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
Figure 80. South America Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Oncology Drug Discovery Services Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel